NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Manitowoc Company, Inc. (:MTW), Omeros Corporation (OMER, Financial), Catabasis Pharmaceuticals, Inc. (CATB, Financial), Zayo Group Holdings, Inc. (:ZAYO), Covanta Holding Corporation (:CVA), and Seattle Genetics, Inc. (SGEN, Financial), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
MTW DOWNLOAD: http://Fundamental-Markets.com/register/?so=MTW
OMER DOWNLOAD: http://Fundamental-Markets.com/register/?so=OMER
CATB DOWNLOAD: http://Fundamental-Markets.com/register/?so=CATB
ZAYO DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZAYO
CVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVA
SGEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=SGEN
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine The Manitowoc Company, Inc. (:MTW), Omeros Corporation (OMER, Financial), Catabasis Pharmaceuticals, Inc. (CATB, Financial), Zayo Group Holdings, Inc. (:ZAYO), Covanta Holding Corporation (:CVA), and Seattle Genetics, Inc. (SGEN, Financial) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
THE MANITOWOC COMPANY, INC. (MTW, Financial) REPORT OVERVIEW
The Manitowoc's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, The Manitowoc reported revenue of $386.10MM vs $305.80MM (up 26.26%) and basic earnings per share -$0.28 vs -$1.03. For the twelve months ended December 31st, 2017 vs December 31st, 2016, The Manitowoc reported revenue of $1,581.30MM vs $1,613.10MM (down 1.97%) and basic earnings per share $0.26 vs -$10.91. The Manitowoc is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $1.49 and is expected to report on February 14th, 2019.
To read the full The Manitowoc Company, Inc. (MTW, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=MTW
-----------------------------------------
OMEROS CORPORATION (OMER, Financial) REPORT OVERVIEW
Omeros' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Omeros reported revenue of $1.59MM vs $12.26MM (down 87.04%) and basic earnings per share -$0.62 vs -$0.34. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Omeros reported revenue of $64.83MM vs $41.62MM (up 55.77%) and basic earnings per share -$1.17 vs -$1.65. Omeros is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.85 and is expected to report on March 7th, 2019.
To read the full Omeros Corporation (OMER, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=OMER
-----------------------------------------
CATABASIS PHARMACEUTICALS, INC. (CATB, Financial) REPORT OVERVIEW
Catabasis Pharmaceuticals' Recent Financial Performance
Catabasis Pharmaceuticals is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.32. The estimated EPS forecast for the next fiscal year is -$1.56 and is expected to report on March 21st, 2019.
To read the full Catabasis Pharmaceuticals, Inc. (CATB, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=CATB
-----------------------------------------
ZAYO GROUP HOLDINGS, INC. (ZAYO, Financial) REPORT OVERVIEW
Zayo Group's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Zayo Group reported revenue of $649.40MM vs $550.20MM (up 18.03%) and basic earnings per share $0.09 vs $0.11 (down 18.18%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Zayo Group reported revenue of $2,199.80MM vs $1,721.70MM (up 27.77%) and basic earnings per share $0.35 vs -$0.31. Zayo Group is expected to report earnings on August 20th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $0.49 and is expected to report on August 20th, 2018.
To read the full Zayo Group Holdings, Inc. (ZAYO, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=ZAYO
-----------------------------------------
COVANTA HOLDING CORPORATION (CVA, Financial) REPORT OVERVIEW
Covanta Holding's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Covanta Holding reported revenue of $458.00MM vs $404.00MM (up 13.37%) and basic earnings per share $1.55 vs -$0.41. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Covanta Holding reported revenue of $1,752.00MM vs $1,699.00MM (up 3.12%) and basic earnings per share $0.44 vs -$0.03. Covanta Holding is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is $0.11 and is expected to report on February 28th, 2019.
To read the full Covanta Holding Corporation (CVA, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=CVA
-----------------------------------------
SEATTLE GENETICS, INC. (SGEN, Financial) REPORT OVERVIEW
Seattle Genetics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Seattle Genetics reported revenue of $140.59MM vs $109.13MM (up 28.83%) and basic earnings per share -$0.73 vs -$0.42. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Seattle Genetics reported revenue of $482.25MM vs $418.15MM (up 15.33%) and basic earnings per share -$0.88 vs -$1.00. Seattle Genetics is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.39. The estimated EPS forecast for the next fiscal year is -$0.81 and is expected to report on February 5th, 2019.
To read the full Seattle Genetics, Inc. (SGEN, Financial) report, download it here: http://Fundamental-Markets.com/register/?so=SGEN
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
